JESSICA HALSTEAD: Open Payments
NPI 1538536693 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,568 in 133 payments from 17 companies in 2025. Trend: 2023 $2,231 · 2024 $2,120 · 2025 $2,568
Food & beverage: $2,561Education: $7
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 26 | $679 |
| AstraZeneca Pharmaceuticals LP | 16 | $536 |
| Genentech USA, Inc. | 14 | $341 |
| GlaxoSmithKline, LLC. | 31 | $275 |
| ARS Pharmaceuticals Operations, Inc. | 21 | $181 |
| ABBVIE INC. | 6 | $167 |
| Incyte Corporation | 4 | $76 |
| GENZYME CORPORATION | 2 | $47 |
| CSL Behring | 2 | $44 |
| LEO Pharma Inc. | 2 | $40 |
Products named: DUPIXENT, Xolair, TEZSPIRE, NUCALA, NEFFY, RINVOQ, AIRSUPRA, FASENRA.
Industry payments across CA — which companies pay providers there.
